| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.006 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.079 | 0.006 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.006 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |